# Contact — BPC-157 TB-500 Editorial Digest (Telehealth Wolverine)

> Contact the BPC-157 TB-500 editorial digest. Editorial correspondence only — not a clinic, not a pharmacy, no medical advice, no prescriptions, nothing for sale.

Editorial correspondence about the Wolverine blend literature — corrections, citations, and questions about the record.

## Editorial correspondence only

This is the contact register for the BPC-157 TB-500 editorial digest. Use the form below for editorial matters: a correction to a citation, a study we should consider for the record, or a question about how a finding is summarized. We read correspondence about the literature and the regulatory record.

What this channel is not: it is not a clinic, not a pharmacy, and not a prescriber. We do not provide medical advice, we do not issue or facilitate prescriptions, we do not sell or supply BPC-157, TB-500, or the Wolverine blend, and we cannot direct anyone to a source. Questions seeking a product, a dose, or a place to obtain either peptide cannot be answered here — those fall outside an editorial project, and the [Wolverine legal status and 503A compounding](/legal-status) page explains why the access question runs only through the lawful prescriber-prescription-compounder pathway [4].

## Send a note

Use the fields below. We respond to editorial correspondence as the record is maintained; we do not respond to requests for medical guidance, dosing, or product sourcing. Please keep messages focused on the published literature and the citations on this site.

---

An instructional scroll of the BPC-157 TB-500 literature, carved register by register and weighed against its sources, with no clinic in the record and nothing here to dispense.